Furthermore, the present study revealed that HBV-HCC with ARID1A deficiency had a higher level of immune cell infiltration in tumour tissues, which is characteristic of the so-called “hot tumour” and is more prone to ICBs [33]. This evidence concerns the gene ARID1A and hepatocellular carcinoma.